227 related articles for article (PubMed ID: 29520218)
1. α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.
Daniele S; Frosini D; Pietrobono D; Petrozzi L; Lo Gerfo A; Baldacci F; Fusi J; Giacomelli C; Siciliano G; Trincavelli ML; Franzoni F; Ceravolo R; Martini C; Bonuccelli U
Front Mol Neurosci; 2018; 11():53. PubMed ID: 29520218
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects.
Daniele S; Pietrobono D; Fusi J; Iofrida C; Chico L; Petrozzi L; Gerfo AL; Baldacci F; Galetta F; Siciliano G; Bonuccelli U; Santoro G; Trincavelli ML; Franzoni F; Martini C
Mol Neurobiol; 2018 Mar; 55(3):2653-2675. PubMed ID: 28421539
[TBL] [Abstract][Full Text] [Related]
3. Influence of physical exercise on β-amyloid, α-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells.
Iofrida C; Daniele S; Pietrobono D; Fusi J; Galetta F; Trincavelli ML; Bonuccelli U; Franzoni F; Martini C
Arch Ital Biol; 2017 Jul; 155(1-2):33-42. PubMed ID: 28715596
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.
Daniele S; Pietrobono D; Fusi J; Lo Gerfo A; Cerri E; Chico L; Iofrida C; Petrozzi L; Baldacci F; Giacomelli C; Galetta F; Siciliano G; Bonuccelli U; Trincavelli ML; Franzoni F; Martini C
Front Aging Neurosci; 2018; 10():17. PubMed ID: 29441013
[TBL] [Abstract][Full Text] [Related]
5. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
Baldacci F; Daniele S; Piccarducci R; Giampietri L; Pietrobono D; Giorgi FS; Nicoletti V; Frosini D; Libertini P; Lo Gerfo A; Petrozzi L; Donadio E; Betti L; Trincavelli ML; Siciliano G; Ceravolo R; Tognoni G; Bonuccelli U; Martini C
Mol Neurobiol; 2019 Sep; 56(9):6451-6459. PubMed ID: 30826968
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease.
Nabizadeh F; Pirahesh K; Ramezannezhad E
Neurol Sci; 2023 Feb; 44(2):573-585. PubMed ID: 36227385
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
[TBL] [Abstract][Full Text] [Related]
8. REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.
Nabizadeh F; Pirahesh K; Valizadeh P
J Neurol; 2022 Sep; 269(9):4836-4845. PubMed ID: 35426534
[TBL] [Abstract][Full Text] [Related]
9. The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
Piccarducci R; Caselli MC; Zappelli E; Ulivi L; Daniele S; Siciliano G; Ceravolo R; Mancuso M; Baldacci F; Martini C
J Alzheimers Dis; 2022; 89(3):1039-1049. PubMed ID: 35964181
[TBL] [Abstract][Full Text] [Related]
10. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
Kang JH; Irwin DJ; Chen-Plotkin AS; Siderowf A; Caspell C; Coffey CS; Waligórska T; Taylor P; Pan S; Frasier M; Marek K; Kieburtz K; Jennings D; Simuni T; Tanner CM; Singleton A; Toga AW; Chowdhury S; Mollenhauer B; Trojanowski JQ; Shaw LM;
JAMA Neurol; 2013 Oct; 70(10):1277-87. PubMed ID: 23979011
[TBL] [Abstract][Full Text] [Related]
11. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson's disease.
Nabizadeh F; Sodeifian F; Kargar A
Acta Neurol Belg; 2023 Aug; 123(4):1429-1437. PubMed ID: 37000407
[TBL] [Abstract][Full Text] [Related]
13. CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease.
Toledo JB; Korff A; Shaw LM; Trojanowski JQ; Zhang J
Acta Neuropathol; 2013 Nov; 126(5):683-97. PubMed ID: 23812319
[TBL] [Abstract][Full Text] [Related]
14. Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease.
Parnetti L; Farotti L; Eusebi P; Chiasserini D; De Carlo C; Giannandrea D; Salvadori N; Lisetti V; Tambasco N; Rossi A; Majbour NK; El-Agnaf O; Calabresi P
Front Aging Neurosci; 2014; 6():53. PubMed ID: 24744728
[TBL] [Abstract][Full Text] [Related]
15. Salivary levels of disease-related biomarkers in the early stages of Parkinson's and Alzheimer's disease:
Sabaei M; Rahimian S; Haj Mohamad Ebrahim Ketabforoush A; Rasoolijazi H; Zamani B; Hajiakhoundi F; Soleimani M; Shahidi G; Faramarzi M
IBRO Neurosci Rep; 2023 Jun; 14():285-292. PubMed ID: 36942319
[TBL] [Abstract][Full Text] [Related]
16. High Levels of
Piccarducci R; Pietrobono D; Pellegrini C; Daniele S; Fornai M; Antonioli L; Trincavelli ML; Blandizzi C; Martini C
Oxid Med Cell Longev; 2019; 2019():5030475. PubMed ID: 31281579
[TBL] [Abstract][Full Text] [Related]
17. CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
Gao R; Zhang G; Chen X; Yang A; Smith G; Wong DF; Zhou Y
PLoS One; 2016; 11(10):e0164762. PubMed ID: 27764160
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease.
Dolatshahi M; Pourmirbabaei S; Kamalian A; Ashraf-Ganjouei A; Yaseri M; Aarabi MH
Front Neurol; 2018; 9():560. PubMed ID: 30050494
[No Abstract] [Full Text] [Related]
19. Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort.
Majbour NK; Abdi IY; Dakna M; Wicke T; Lang E; Ali Moussa HY; Thomas MA; Trenkwalder C; Safieh-Garabedian B; Tokuda T; Mollenhauer B; El-Agnaf O
Mov Disord; 2021 Sep; 36(9):2048-2056. PubMed ID: 33978256
[TBL] [Abstract][Full Text] [Related]
20. CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.
Irwin DJ; Xie SX; Coughlin D; Nevler N; Akhtar RS; McMillan CT; Lee EB; Wolk DA; Weintraub D; Chen-Plotkin A; Duda JE; Spindler M; Siderowf A; Hurtig HI; Shaw LM; Grossman M; Trojanowski JQ
Neurology; 2018 Mar; 90(12):e1038-e1046. PubMed ID: 29467305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
